These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4374062)

  • 1. Depigmentation in the nerve cells of the substantia nigra and locus ceruleus in Parkinsonism.
    Forno LS; Alvord EC
    Adv Neurol; 1974; 5():195-202. PubMed ID: 4374062
    [No Abstract]   [Full Text] [Related]  

  • 2. The pathology of Parkinsonism: a comparison of degenerations in cerebral cortex and brainstem.
    Alvord EC; Forno LS; Kusske JA; Kauffman RJ; Rhodes JS; Goetowski CR
    Adv Neurol; 1974; 5():175-93. PubMed ID: 4374061
    [No Abstract]   [Full Text] [Related]  

  • 3. The anatomy and pigmentation of the human substantia nigra in relation to selective neuronal vulnerability.
    Gibb WR; Fearnley JM; Lees AJ
    Adv Neurol; 1990; 53():31-4. PubMed ID: 2173373
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease.
    Sasaki M; Shibata E; Tohyama K; Takahashi J; Otsuka K; Tsuchiya K; Takahashi S; Ehara S; Terayama Y; Sakai A
    Neuroreport; 2006 Jul; 17(11):1215-8. PubMed ID: 16837857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromelanin and Parkinson's disease.
    Marsden CD
    J Neural Transm Suppl; 1983; 19():121-41. PubMed ID: 6321645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pathological study of the association between Lewy body disease and Alzheimer's disease.
    Gibb WR; Mann DM; Mountjoy CQ; Lees AJ
    Adv Neurol; 1990; 53():55-9. PubMed ID: 2173375
    [No Abstract]   [Full Text] [Related]  

  • 7. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.
    Hill WD; Arai M; Cohen JA; Trojanowski JQ
    J Comp Neurol; 1993 Mar; 329(3):328-36. PubMed ID: 8459049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Lewy body in Parkinson's disease.
    Forno LS
    Adv Neurol; 1987; 45():35-43. PubMed ID: 3030070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship among alpha-synuclein accumulation, dopamine synthesis, and neurodegeneration in Parkinson disease substantia nigra.
    Mori F; Nishie M; Kakita A; Yoshimoto M; Takahashi H; Wakabayashi K
    J Neuropathol Exp Neurol; 2006 Aug; 65(8):808-15. PubMed ID: 16896314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrastructural observations in Parkinsonism.
    Roy S; Wolman L
    J Pathol; 1969 Sep; 99(1):39-44. PubMed ID: 5359222
    [No Abstract]   [Full Text] [Related]  

  • 12. "Minimal change" multiple system atrophy.
    Wenning GK; Quinn N; Magalhăes M; Mathias C; Daniel SE
    Mov Disord; 1994 Mar; 9(2):161-6. PubMed ID: 8196676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron and ferritin in substantia nigra in Parkinson's disease.
    Jellinger KA; Kienzl E; Rumpelmaier G; Paulus W; Riederer P; Stachelberger H; Youdim MB; Ben-Shachar D
    Adv Neurol; 1993; 60():267-72. PubMed ID: 8420142
    [No Abstract]   [Full Text] [Related]  

  • 14. Fine structure of neuronal spherical arginine-rich bodies of substantia nigra and locus coeruleus in the human brain.
    Issidorides MR; Pappas GD
    Hum Neurobiol; 1988; 6(4):239-46. PubMed ID: 2832354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions.
    Chu Y; Dodiya H; Aebischer P; Olanow CW; Kordower JH
    Neurobiol Dis; 2009 Sep; 35(3):385-98. PubMed ID: 19505575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A 78-year-old man with young onset parkinsonism and sudden death].
    Miyasaka H; Mori H; Saikawa T; Shirai T; Kondo T; Imai H; Mizuno Y
    No To Shinkei; 1996 May; 48(5):487-95. PubMed ID: 8672309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Incidental occurrence of Lewy bodies in the brains of elderly patients--the relevance to aging and Parkinson's disease].
    Wakabayashi K; Takahashi H; Oyanagi K; Ikuta F
    No To Shinkei; 1993 Nov; 45(11):1033-8. PubMed ID: 8135950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemistry of neuromelanin.
    Van Woert MH; Ambani LM
    Adv Neurol; 1974; 5():215-23. PubMed ID: 4374063
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra.
    Howells DW; Porritt MJ; Wong JY; Batchelor PE; Kalnins R; Hughes AJ; Donnan GA
    Exp Neurol; 2000 Nov; 166(1):127-35. PubMed ID: 11031089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?
    Chu Y; Kordower JH
    Neurobiol Dis; 2007 Jan; 25(1):134-49. PubMed ID: 17055279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.